SPOTLIGHT -
Slideshow
Author(s):
A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.
Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia
Treating ‘Morally Objectionable’ Patients
The Dawn of a New Era for Schizophrenia
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial
Treating Schizophrenia: Bringing Together Pharmacists and Clinicians for Patient Care